Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PharmAthene PIP

Healthcare Biotechnology
"PharmAthene Inc is a biodefense company. It is engaged in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States."

Recent & Breaking News (NYSEAM:PIP)

PharmAthene and Nanotherapeutics Form Strategic Alliance to Advance Biodefense Programs

PR Newswire September 8, 2014

Delaware Court of Chancery Orders SIGA To Pay PharmAthene Lump Sum Expectation Damages

PR Newswire August 10, 2014

PharmAthene Reports Second Quarter 2014 Financial And Operational Results

PR Newswire August 4, 2014

PharmAthene Granted U.S. Patent For Recombinant Bioscavenger

PR Newswire June 9, 2014

PharmAthene Presents New SparVax® Anthrax Vaccine Data At The FDA Medical Countermeasures Initiative Symposium

PR Newswire June 4, 2014

PIPEHAWK PLC - Director Holding

PR Newswire May 30, 2014

PharmAthene Presents New SparVax® Anthrax Vaccine Data At The American Society For Microbiology 2014 Meeting

PR Newswire May 29, 2014

PharmAthene Reports First Quarter 2014 Financial And Operational Results

PR Newswire May 8, 2014

PharmAthene Updates Status Of SparVax® Anthrax Vaccine Contract

PR Newswire April 7, 2014

PharmAthene Presents SparVax® Anthrax Vaccine Data at the New Technologies New Vaccines 2014 Conference

PR Newswire April 1, 2014

PIPEHAWK PLC - Holding(s) in Company

PR Newswire March 25, 2014

PharmAthene Reports Year-End 2013 Financial And Operational Results

PR Newswire March 11, 2014

PharmAthene to Host Year-End 2013 Conference Call and Webcast on Tuesday, March 11, 2014

PR Newswire March 10, 2014

PIPEHAWK PLC - Half-yearly Report

PR Newswire March 10, 2014

PharmAthene Receives FDA Notification On SparVax®

PR Newswire December 16, 2013

PharmAthene Announces Termination Of Merger Agreement With Theraclone Sciences

PR Newswire December 2, 2013

Update - Prescott Group Urges All PharmAthene Shareholders to Vote Against Proposed Theraclone Merger

Business Wire November 29, 2013

Prescott Group Urges All PharmAthene Shareholders to Vote AGAINST Proposed Theraclone Merger

Business Wire November 27, 2013

PIPEHAWK PLC - Holding(s) in Company

PR Newswire November 26, 2013

PIPEHAWK PLC - Notice of AGM

PR Newswire November 13, 2013